Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines

Department

Research

Document Type

Article

Publication Title

PloS one

Abstract

The tight control of proliferating keratinocytes is vital to the successful function of the skin. Differentiation of dividing cells is necessary to form a skin barrier. The same dividing cells are necessary to heal wounds and when malignant form tumors. RIPK4, a serine-threonine kinase, plays critical roles in these processes. Its loss of function was associated with pathological keratinocyte proliferation and development of squamous cell carcinoma (SCC) in humans and mice. The current study extends previous findings in the importance of RIPK4 in keratinocyte proliferation. A serum-derived phospholipid, lysophosphatidic acid (LPA), was identified as an important biologic inhibitor of RIPK4. LPA functions by inhibiting the transcription of RIPK4 mRNA. LPA treatment led to increased keratinocyte proliferation, and this was compromised in cells with reduced RIPK4 expression. The current study may help to explain the mechanism by which RIPK4 was downregulated during SCC progression and provide insights on RIPK4 functions. It may also allow for targeting of RIPK4 through a natural component of serum.

First Page

e0287444

DOI

10.1371/journal.pone.0287444

Volume

19

Issue

4

Publication Date

4-1-2024

Medical Subject Headings

Humans; Animals; Mice; RNA, Messenger (metabolism); Protein Serine-Threonine Kinases (metabolism); Keratinocytes (metabolism); Carcinoma, Squamous Cell (pathology); Cell Line; Lysophospholipids

PubMed ID

38630705

Link to Full Text

Share

COinS